TY - JOUR
T1 - Effect of prednisolone on blood coagulation in primary glomerular diseases
AU - Akiu, Naoki
AU - Sato, Hiroshi
AU - Saito, Takao
AU - Yoshinaga, Kaoru
AU - Sugai, Koji
AU - Akutsu, Yasuyuki
AU - Mori, Kazuo
AU - Furuyama, Takashi
N1 - Copyright:
Copyright 2016 Elsevier B.V., All rights reserved.
PY - 1986
Y1 - 1986
N2 - Hypercoagulability is considered as one of the exacerbating factors in glomerular diseases. It is important to investigate the effect of glucocorticoids on blood coagulation which may accelerate the coagulation system. To study this problem, we performed several coagulation tests before and after the treatment of prednisolone in 16 patients with primary glomerular diseases (Membranous Nephropathy 7 cases, Mesangial Proliferative Glomerulonephritis 5, Membranoproliferative Glomerulonephritis 2 and Focal Glomerular Sclerosis 2). The results were as follows-The procoagulant activities of blood coagulation factor VIII, IX and XII were significantly elevated, and activated partial thromboplastin time was shortened. This shortening was dependent on the daily dose of prednisolone. The level of von Willebrand factor activity was elevated. The platelet aggregation rate induced by collagen and ristocetin and the release of ATP induced by ADP and collagen were also elevated. On the other hand, antithrombin III was increased, and fibrinogen was decreased. In addition, total cholesterol was elevated, and urinary protein and creatinine clearance remained to be unchanged. The results showed that a hypercoagulable state was induced by the administration of prednisolone in primary glomerular diseases. Therefore, it is suggested that prednisolone may accelerate the intraglomerular coagulation and other thromboembolic processes. It might be necessary to use the anticoagulants and/or antiplatelet agents against these side effects of glucocorticoids.
AB - Hypercoagulability is considered as one of the exacerbating factors in glomerular diseases. It is important to investigate the effect of glucocorticoids on blood coagulation which may accelerate the coagulation system. To study this problem, we performed several coagulation tests before and after the treatment of prednisolone in 16 patients with primary glomerular diseases (Membranous Nephropathy 7 cases, Mesangial Proliferative Glomerulonephritis 5, Membranoproliferative Glomerulonephritis 2 and Focal Glomerular Sclerosis 2). The results were as follows-The procoagulant activities of blood coagulation factor VIII, IX and XII were significantly elevated, and activated partial thromboplastin time was shortened. This shortening was dependent on the daily dose of prednisolone. The level of von Willebrand factor activity was elevated. The platelet aggregation rate induced by collagen and ristocetin and the release of ATP induced by ADP and collagen were also elevated. On the other hand, antithrombin III was increased, and fibrinogen was decreased. In addition, total cholesterol was elevated, and urinary protein and creatinine clearance remained to be unchanged. The results showed that a hypercoagulable state was induced by the administration of prednisolone in primary glomerular diseases. Therefore, it is suggested that prednisolone may accelerate the intraglomerular coagulation and other thromboembolic processes. It might be necessary to use the anticoagulants and/or antiplatelet agents against these side effects of glucocorticoids.
KW - blood coagulation factors
KW - glomerular diseases
KW - glucocorticoids
KW - hypercoagulable state
KW - platelet aggregation
UR - http://www.scopus.com/inward/record.url?scp=0022852292&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022852292&partnerID=8YFLogxK
U2 - 10.14842/jpnjnephrol1959.28.1429
DO - 10.14842/jpnjnephrol1959.28.1429
M3 - Article
C2 - 3820820
AN - SCOPUS:0022852292
VL - 28
SP - 1429
EP - 1436
JO - Japanese Journal of Nephrology
JF - Japanese Journal of Nephrology
SN - 0385-2385
IS - 11
ER -